Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
1.
Biotechnol Prog ; 35(2): e2770, 2019 03.
Article in English | MEDLINE | ID: mdl-30592187

ABSTRACT

Fields such as, diagnostic testing, biotherapeutics, drug development, and toxicology among others, center on the premise of searching through many specimens for a rare event. Scientists in the business of "searching for a needle in a haystack" may greatly benefit from the use of group screening design strategies. Group screening, where specimens are composited into pools with each pool being tested for the presence of the event, can be much more cost-efficient than testing each individual specimen. A number of group screening designs have been proposed in the literature. Incomplete block screening designs are described here and compared with other group screening designs. It is shown under certain conditions, that incomplete block screening designs can provide nearly a 90% cost saving compared to other group screening designs such as when prevalence is 0.001 and screening 3876 specimens with an ICB-sequential design vs. a Dorfman design. In other cases, previous group screening designs are shown to be most efficient. Overall, when prevalence is small (≤0.05) group screening designs are shown to be quite cost effective at screening a large number of specimens and in general there is no one design that is best in all situations. © 2018 American Institute of Chemical Engineers Biotechnol Progress, 35: e2770, 2019.


Subject(s)
Cost-Benefit Analysis , Pharmaceutical Preparations/economics , Statistics as Topic
2.
Biometrics ; 73(3): 927-937, 2017 09.
Article in English | MEDLINE | ID: mdl-28131108

ABSTRACT

In this article, we present a new method for optimizing designs of experiments for non-linear mixed effects models, where a categorical factor with covariate information is a design variable combined with another design factor. The work is motivated by the need to efficiently design preclinical experiments in enzyme kinetics for a set of Human Liver Microsomes. However, the results are general and can be applied to other experimental situations where the variation in the response due to a categorical factor can be partially accounted for by a covariate. The covariate included in the model explains some systematic variability in a random model parameter. This approach allows better understanding of the population variation as well as estimation of the model parameters with higher precision.


Subject(s)
Nonlinear Dynamics , Computer Simulation , Humans , Microsomes, Liver
4.
Stat Methods Med Res ; 24(3): 306-24, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25038072

ABSTRACT

Transform-both-sides nonlinear models have proved useful in many experimental applications including those in pharmaceutical sciences and biochemistry. The maximum likelihood method is commonly used to fit transform-both-sides nonlinear models, where the regression and transformation parameters are estimated simultaneously. In this paper, an analysis of variance-based method is described in detail for estimating transform-both-sides nonlinear models from randomized experiments. It estimates the transformation parameter from the full treatment model and then the regression parameters are estimated conditionally on this estimate of the transformation parameter. The analysis of variance method is computationally simpler compared with the maximum likelihood method of estimation and allows a more natural separation of different sources of lack of fit. Simulation studies show that the analysis of variance method can provide unbiased estimators of complex transform-both-sides nonlinear models, such as transform-both-sides random coefficient nonlinear regression models and transform-both-sides fixed coefficient nonlinear regression models with random block effects.


Subject(s)
Nonlinear Dynamics , Pharmacokinetics , Analysis of Variance , Humans , In Vitro Techniques , Likelihood Functions , Models, Statistical , Regression Analysis
5.
Biometrics ; 62(2): 323-31, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16918896

ABSTRACT

Many processes in the biological industries are studied using response surface methodology. The use of biological materials, however, means that run-to-run variation is typically much greater than that in many experiments in mechanical or chemical engineering and so the designs used require greater replication. The data analysis which is performed may involve some variable selection, as well as fitting polynomial response surface models. This implies that designs should allow the parameters of the model to be estimated nearly orthogonally. A class of three-level response surface designs is introduced which allows all except the quadratic parameters to be estimated orthogonally, as well as having a number of other useful properties. These subset designs are obtained by using two-level factorial designs in subsets of the factors, with the other factors being held at their middle level. This allows their properties to be easily explored. Replacing some of the two-level designs with fractional replicates broadens the class of useful designs, especially with five or more factors, and sometimes incomplete subsets can be used. It is very simple to include a few two- and four-level factors in these designs by excluding subsets with these factors at the middle level. Subset designs can be easily modified to include factors with five or more levels by allowing a different pair of levels to be used in different subsets.


Subject(s)
Biomedical Engineering/statistics & numerical data , Biometry , Biocompatible Materials , Biotechnology , Models, Statistical , Surface Properties
6.
Genetics ; 174(2): 945-57, 2006 Oct.
Article in English | MEDLINE | ID: mdl-16888340

ABSTRACT

Microarray experiments have been used recently in genetical genomics studies, as an additional tool to understand the genetic mechanisms governing variation in complex traits, such as for estimating heritabilities of mRNA transcript abundances, for mapping expression quantitative trait loci, and for inferring regulatory networks controlling gene expression. Several articles on the design of microarray experiments discuss situations in which treatment effects are assumed fixed and without any structure. In the case of two-color microarray platforms, several authors have studied reference and circular designs. Here, we discuss the optimal design of microarray experiments whose goals refer to specific genetic questions. Some examples are used to illustrate the choice of a design for comparing fixed, structured treatments, such as genotypic groups. Experiments targeting single genes or chromosomic regions (such as with transgene research) or multiple epistatic loci (such as within a selective phenotyping context) are discussed. In addition, microarray experiments in which treatments refer to families or to subjects (within family structures or complex pedigrees) are presented. In these cases treatments are more appropriately considered to be random effects, with specific covariance structures, in which the genetic goals relate to the estimation of genetic variances and the heritability of transcriptional abundances.


Subject(s)
Genomics/methods , Oligonucleotide Array Sequence Analysis/methods , Research Design , Animals , Genomics/standards , Humans , Oligonucleotide Array Sequence Analysis/standards
7.
Med Chem ; 1(1): 21-9, 2005 Jan.
Article in English | MEDLINE | ID: mdl-16789882

ABSTRACT

We demonstrate that a Bayesian approach (the use of prior knowledge) to the design of steady-state experiments can produce major gains quantifiable in terms of information, productivity and accuracy of each experiment. Developing the use of Bayesian utility functions, we have used a systematic method to identify the optimum experimental designs for a number of kinetic model data sets. This has enabled the identification of trends between kinetic model types, sets of design rules and the key conclusion that such designs should be based on some prior knowledge of the kinetic model. We suggest an optimal and iterative method for selecting features of the design such as the substrate range, number of measurements and choice of intermediate points. The final design collects data suitable for accurate modelling and analysis and minimises the error in the parameters estimated. It is equally applicable to enzymes, drug transport, receptor binding, microbial culture and cell transport kinetics.


Subject(s)
Drug Design , Enzymes , Pharmacokinetics , Receptors, Cell Surface , Research Design , Bayes Theorem , Cell Culture Techniques , Computer Simulation , Kinetics , Lactoylglutathione Lyase/metabolism , Protein Binding
8.
FEBS Lett ; 556(1-3): 193-8, 2004 Jan 02.
Article in English | MEDLINE | ID: mdl-14706849

ABSTRACT

Details about the parameters of kinetic systems are crucial for progress in both medical and industrial research, including drug development, clinical diagnosis and biotechnology applications. Such details must be collected by a series of kinetic experiments and investigations. The correct design of the experiment is essential to collecting data suitable for analysis, modelling and deriving the correct information. We have developed a systematic and iterative Bayesian method and sets of rules for the design of enzyme kinetic experiments. Our method selects the optimum design to collect data suitable for accurate modelling and analysis and minimises the error in the parameters estimated. The rules select features of the design such as the substrate range and the number of measurements. We show here that this method can be directly applied to the study of other important kinetic systems, including drug transport, receptor binding, microbial culture and cell transport kinetics. It is possible to reduce the errors in the estimated parameters and, most importantly, increase the efficiency and cost-effectiveness by reducing the necessary amount of experiments and data points measured.


Subject(s)
Bayes Theorem , Pharmacokinetics , Receptors, Cell Surface/metabolism , Biological Transport , Cell Line, Tumor , Costs and Cost Analysis , Glioma/metabolism , Humans , Kinetics , Microbiological Techniques , Models, Biological , Models, Chemical , Research Design , Sensitivity and Specificity
9.
Biometrics ; 59(2): 375-81, 2003 Jun.
Article in English | MEDLINE | ID: mdl-12926722

ABSTRACT

Selection trials in plant and animal breeding, in incomplete blocks, are described by linear models with random effect parameters associated with treatments with known genetic covariance structure. It is now well known that the information on relatives can improve the analysis and many extensions of this model have been proposed, but no studies have been done on the consequences of this genetical relatedness among treatments for the optimality of block designs. Using a suitable optimality criterion, we show that the knowledge on relatedness may imply that the optimal design is not in the class of designs which are optimal for unrelated treatments. Implications for practical applications are discussed.


Subject(s)
Breeding/methods , Models, Genetic , Plants/genetics , Selection, Genetic , Animals , Linear Models , Pedigree , Research Design
10.
J Biochem Biophys Methods ; 55(2): 155-78, 2003 Feb 28.
Article in English | MEDLINE | ID: mdl-12628698

ABSTRACT

In areas such as drug development, clinical diagnosis and biotechnology research, acquiring details about the kinetic parameters of enzymes is crucial. The correct design of an experiment is critical to collecting data suitable for analysis, modelling and deriving the correct information. As classical design methods are not targeted to the more complex kinetics being frequently studied, attention is needed to estimate parameters of such models with low variance. We demonstrate that a Bayesian approach (the use of prior knowledge) can produce major gains quantifiable in terms of information, productivity and accuracy of each experiment. Developing the use of Bayesian Utility functions, we have used a systematic method to identify the optimum experimental designs for a number of kinetic model data sets. This has enabled the identification of trends between kinetic model types, sets of design rules and the key conclusion that such designs should be based on some prior knowledge of K(M) and/or the kinetic model. We suggest an optimal and iterative method for selecting features of the design such as the substrate range, number of measurements and choice of intermediate points. The final design collects data suitable for accurate modelling and analysis and minimises the error in the parameters estimated.


Subject(s)
Bayes Theorem , Combinatorial Chemistry Techniques/methods , Enzymes/chemistry , Models, Chemical , Research Design , Cytochrome P-450 Enzyme System/chemistry , Enzyme Activation , Kinetics , Lactoylglutathione Lyase/chemistry , Models, Biological , Models, Statistical , Reproducibility of Results , Sensitivity and Specificity , Substrate Specificity
11.
Drug Discov Today ; 7(20 Suppl): S187-91, 2002 Oct 15.
Article in English | MEDLINE | ID: mdl-12546904

ABSTRACT

Acquiring details about the kinetic parameters of enzymes is crucial to both drug development and clinical diagnosis. The correct design of an experiment is crucial to collecting data suitable for analysis, modelling and deriving the correct information. As classical design methods are not targeted to the more complex kinetics now frequently studied, further work is required to estimate parameters of such models with low variance. This review examines the different options available to produce major gains in information, productivity and the accuracy of each experiment.


Subject(s)
Computational Biology/trends , Enzymes/metabolism , Animals , Bayes Theorem , Humans , Kinetics , Pharmacology , Research Design
SELECTION OF CITATIONS
SEARCH DETAIL
...